Navigation Links
Study Helps Medical Education Leaders Navigate the New Regulatory and Financial Landscape
Date:8/8/2014

CHAPEL HILL, N.C., Aug. 8, 2014 /PRNewswire/ -- Medical education leaders in the medical device and pharmaceutical sectors are finding it challenging to navigate the current regulatory and financial landscape.

These challenges - one affecting program content and delivery and the other affecting resources - have made it even more important for medical education groups to effectively reach physicians and to efficiently use their resources.

To help medical education leaders succeed in this environment, research and consulting firm Best Practices, LLC conducted a study that pinpoints how organizations are developing and delivering education programs and which presenters and venues have the highest impact for physicians. In addition, the study reviews how companies are allocating their education budgets and developing performance measures to demonstrate their group's effectiveness.

The study, "Professional Medical Education Excellence: Benchmarking Critical Program Trends Transforming the Medical Device and Biopharmaceutical Marketplace," provides segments for both pharmaceutical and medical device companies.

One of the study's findings was that a majority of organizations in both the device and pharma segments expect their multi-disciplinary programs to increase in the next 2-3 years. With healthcare reform putting a greater emphasis on health outcomes, some education leaders believe the emphasis on coordination of care inherent in multi-disciplinary programs is behind the expected growth.

Other benchmarks and insights in the study include:

  • The funding channels utilized by medical education groups
  • The effectiveness of different medical education program types and delivery channels
  • The use of multi-disciplinary medical education programs
  • Future trends in medical education programs and technology

The study also informs education leaders on education trends in emerging markets.

The research project includes observations and insights from 32 leaders with 31 medical device and pharmaceutical companies. Participants included 14 medical education leaders from 14 medical device firms and 18 leaders from 17 biopharmaceutical companies.

To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1305.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Initiation of Phase 2 Clinical Study of CCH for Treatment of Lipoma
2. For Second Year in a Row, RIVA Named Top IV Robot in Study Ranking Pharmacy Automation
3. KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data
4. Kaiser Permanente Study Finds Shingles Vaccine Remains Effective After Chemotherapy
5. Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce First Patient Dosed in Phase II Study of VPD-737 in Prurigo Nodularis
6. Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
7. New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015
8. EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
9. Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers
10. Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children
11. Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017  Noble ... coverage on ESSA Pharma Inc. (Nasdaq: EPIX ... Biotechnology Research, Kumar Raja , PhD. ... treatments for castration resistant prostate cancer (CRPC). Its lead ... selectively blocks the amino-terminal domain of the androgen receptor, ...
Breaking Medicine Technology:
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer ... Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As part of ... anatomic and molecular pathology workflow solution, as well as its new precision medicine ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):